thiazoles has been researched along with gsk3235025 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, W; Duan, S; Gao, Y; He, J; Huang, G; Jiang, A; Liu, X; Mao, L; Sang, Y; Zhang, Y | 1 |
1 other study(ies) available for thiazoles and gsk3235025
| Article | Year |
|---|---|
EPZ015666, a selective protein arginine methyltransferase 5 (PRMT5) inhibitor with an antitumour effect in retinoblastoma.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Immunohistochemistry; Isoquinolines; Male; Mice; Mice, Nude; Protein-Arginine N-Methyltransferases; Pyrimidines; Real-Time Polymerase Chain Reaction; Retinal Neoplasms; Retinoblastoma; Tetrazolium Salts; Thiazoles; Time Factors; Transplantation, Heterologous | 2021 |